FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2089968196> ?p ?o ?g. }

• W2089968196 endingPage "369" @default.
• W2089968196 startingPage "363" @default.
• W2089968196 abstract "Microparticles (MP) can be elevated in cancer and thromboembolic disease. We hypothesized a role for MP in the hypercoagulable state in breast cancer patients using endocrine therapy, in whom both cancer and the use of endocrine therapy are independent risk factors for the development of thrombosis.Plasma samples were collected from 40 breast cancer patients using endocrine therapy (20 patients without metastases receiving adjuvant therapy and 20 patients with metastatic disease treated in a palliative setting) and from 20 female healthy controls. The endocrine therapy used was either an anti-estrogen or an aromatase inhibitor. Numbers and cellular origin of MP subsets were analyzed by flowcytometry. MP-associated procoagulant activity was measured using a thrombin generation assay using conditions that allow analysis of MP induced thrombin generation.Breast cancer patients using endocrine therapy had higher levels of MP positive for Annexin V (median 10000 vs 6500×10E6/l), P-selectin (330 vs 200×10E6/l), tissue factor (33 vs 15×10E6/l), and of MP derived from platelets (CD41) and leukocytes (CD45). Thrombin generation in plasma was dependent on the presence of MP and thrombin generation performed after addition of isolated MP to normal plasma showed a higher endogenous thrombin potential (1105 vs 1029 nM.min) in breast cancer patients. No differences were observed in MP levels and thrombin generation parameters between the metastatic and adjuvant group.Breast cancer patients using endocrine therapy have an increased MP number and a higher MP-dependent thrombin generation, irrespective of the presence of metastatic disease. Altered MP subset characteristics in these patients, especially the higher number of (activated) platelet derived MP and leukocyte derived MP, may in part explain a heightened procoagulant state in breast cancer patients using endocrine therapy." @default.
• W2089968196 created "2016-06-24" @default.
• W2089968196 creator A5016667181 @default.
• W2089968196 creator A5021845555 @default.
• W2089968196 creator A5034309539 @default.
• W2089968196 creator A5035181650 @default.
• W2089968196 creator A5036735210 @default.
• W2089968196 creator A5061983997 @default.
• W2089968196 creator A5073188418 @default.
• W2089968196 creator A5076109573 @default.
• W2089968196 date "2011-04-01" @default.
• W2089968196 modified "2023-09-27" @default.
• W2089968196 title "Elevated numbers and altered subsets of procoagulant microparticles in breast cancer patients using endocrine therapy" @default.
• W2089968196 cites W1571397203 @default.
• W2089968196 cites W1963615815 @default.
• W2089968196 cites W1971784120 @default.
• W2089968196 cites W1986747192 @default.
• W2089968196 cites W2003726111 @default.
• W2089968196 cites W2012535096 @default.
• W2089968196 cites W2028513701 @default.
• W2089968196 cites W2040202424 @default.
• W2089968196 cites W2048018195 @default.
• W2089968196 cites W2059215414 @default.
• W2089968196 cites W2068318554 @default.
• W2089968196 cites W2099920676 @default.
• W2089968196 cites W2107383916 @default.
• W2089968196 cites W2107387858 @default.
• W2089968196 cites W2117243202 @default.
• W2089968196 cites W2121656289 @default.
• W2089968196 cites W2123409535 @default.
• W2089968196 cites W2124339684 @default.
• W2089968196 cites W2129464080 @default.
• W2089968196 cites W2155066067 @default.
• W2089968196 cites W2156877554 @default.
• W2089968196 cites W2163438647 @default.
• W2089968196 cites W2163688875 @default.
• W2089968196 cites W2167661845 @default.
• W2089968196 cites W2168236819 @default.
• W2089968196 cites W2270373849 @default.
• W2089968196 cites W2408854760 @default.
• W2089968196 cites W4237673320 @default.
• W2089968196 cites W4249976229 @default.
• W2089968196 cites W4250054871 @default.
• W2089968196 doi "https://doi.org/10.1016/j.thromres.2010.12.015" @default.
• W2089968196 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21272922" @default.
• W2089968196 hasPublicationYear "2011" @default.
• W2089968196 type Work @default.
• W2089968196 sameAs 2089968196 @default.
• W2089968196 citedByCount "29" @default.
• W2089968196 countsByYear W20899681962012 @default.
• W2089968196 countsByYear W20899681962013 @default.
• W2089968196 countsByYear W20899681962014 @default.
• W2089968196 countsByYear W20899681962015 @default.
• W2089968196 countsByYear W20899681962016 @default.
• W2089968196 countsByYear W20899681962017 @default.
• W2089968196 countsByYear W20899681962019 @default.
• W2089968196 countsByYear W20899681962020 @default.
• W2089968196 countsByYear W20899681962022 @default.
• W2089968196 countsByYear W20899681962023 @default.
• W2089968196 crossrefType "journal-article" @default.
• W2089968196 hasAuthorship W2089968196A5016667181 @default.
• W2089968196 hasAuthorship W2089968196A5021845555 @default.
• W2089968196 hasAuthorship W2089968196A5034309539 @default.
• W2089968196 hasAuthorship W2089968196A5035181650 @default.
• W2089968196 hasAuthorship W2089968196A5036735210 @default.
• W2089968196 hasAuthorship W2089968196A5061983997 @default.
• W2089968196 hasAuthorship W2089968196A5073188418 @default.
• W2089968196 hasAuthorship W2089968196A5076109573 @default.
• W2089968196 hasConcept C121608353 @default.
• W2089968196 hasConcept C126322002 @default.
• W2089968196 hasConcept C134018914 @default.
• W2089968196 hasConcept C143998085 @default.
• W2089968196 hasConcept C186738567 @default.
• W2089968196 hasConcept C2775930923 @default.
• W2089968196 hasConcept C2777292125 @default.
• W2089968196 hasConcept C2777982462 @default.
• W2089968196 hasConcept C2778382381 @default.
• W2089968196 hasConcept C46699223 @default.
• W2089968196 hasConcept C530470458 @default.
• W2089968196 hasConcept C71315377 @default.
• W2089968196 hasConcept C71924100 @default.
• W2089968196 hasConcept C89560881 @default.
• W2089968196 hasConcept C90924648 @default.
• W2089968196 hasConceptScore W2089968196C121608353 @default.
• W2089968196 hasConceptScore W2089968196C126322002 @default.
• W2089968196 hasConceptScore W2089968196C134018914 @default.
• W2089968196 hasConceptScore W2089968196C143998085 @default.
• W2089968196 hasConceptScore W2089968196C186738567 @default.
• W2089968196 hasConceptScore W2089968196C2775930923 @default.
• W2089968196 hasConceptScore W2089968196C2777292125 @default.
• W2089968196 hasConceptScore W2089968196C2777982462 @default.
• W2089968196 hasConceptScore W2089968196C2778382381 @default.
• W2089968196 hasConceptScore W2089968196C46699223 @default.
• W2089968196 hasConceptScore W2089968196C530470458 @default.
• W2089968196 hasConceptScore W2089968196C71315377 @default.
• W2089968196 hasConceptScore W2089968196C71924100 @default.
• W2089968196 hasConceptScore W2089968196C89560881 @default.
• W2089968196 hasConceptScore W2089968196C90924648 @default.

• next